摘要
Keywords: Recurrent ischemic stroke; HET3 mice; Photothrombotic stroke; Middle cerebral artery occlusion; Brain infarct; Neurological deficits; Ageing; Preclinical stroke model.
Background: Recurrent stroke affects 5–20% of stroke survivors within two years of their initial event, and is associated with increased mortality, greater neurological disability and poorer functional outcomes compared with a first-ever stroke. However, its pathological consequences remain poorly understood. Furthermore, a well-characterised and consistent preclinical model of recurrent ischemic stroke has yet to be established, particularly in aged mice. Here, we aimed to establish and characterise a preclinical model of recurrent ischemic stroke and compare brain injury profiles between single and recurrent stroke in aged mice.
Methods: Aged outbred HET3 mice (16–23 months) of both sexes underwent photothrombotic (PT) stroke surgery targeting the right primary motor cortex to induce the first stroke. Mice in the single-stroke group underwent sham surgery instead. Ten days later, all mice underwent 30-minute right middle cerebral artery occlusion (MCAO) to model a recurrent stroke in the PT group. Functional outcomes were assessed 24 h after MCAO, and brain infarct volumes were quantified.
Results: In aged HET3 mice, MCAO-induced infarct volume was approximately four times greater in the recurrent-stroke group (n=12) than in the single-stroke group (n=6) (P=0.005). In mice subjected to recurrent stroke, females exhibited significantly greater initial PT-induced infarct volumes than males (P=0.0446). However, no sex-dependent differences were observed in MCAO-induced infarct volume. No significant differences were detected in neurological scores or hanging wire performance between the single- and recurrent-stroke groups.
Conclusion: This study establishes a preclinical model of recurrent ischemic stroke in aged HET3 mice. Recurrent ischemic events resulted in substantially greater brain injury compared with a single stroke. This model provides a valuable platform for investigating the mechanisms contributing to augmented recurrent strokes in aged, outbred animals while accounting for biological variability, which may potentially provide translational relevance for clinical stroke therapy.
